Optimal vaccinations: Cordons sanitaires, reducible population and optimal rays
Jean-Fran\c{c}ois Delmas, Dylan Dronnier, Pierre-Andr\'e Zitt

TL;DR
This paper explores optimal vaccination strategies in complex populations, balancing cost and infection control, and introduces graph-theoretic and spectral methods to identify effective vaccination policies.
Contribution
It provides explicit formulas and conditions for optimal vaccination strategies in infinite-dimensional populations, challenging the effectiveness of cordon sanitaire approaches.
Findings
Cordon sanitaire may not be optimal but outperforms worst strategies.
Explicit formulas for best and worst vaccination strategies are derived.
Conditions for scaling optimal strategies to remain optimal are established.
Abstract
We consider the bi-objective problem of allocating doses of a (perfect) vaccine to an infinite-dimensional metapopulation in order to minimize simultaneously the vaccination cost and the effective reproduction number , which is defined as the spectral radius of the effective next-generation operator. In this general framework, we prove that a cordon sanitaire, that is, a strategy that effectively disconnects the non-vaccinated population, might not be optimal, but it is still better than the "worst" vaccination strategies. Inspired by graph theory, we also compute the minimal cost which ensures that no infection occurs using independent sets. Using Frobenius decomposition of the whole population into irreducible sub-populations, we give some explicit formulae for optimal ("best" and "worst") vaccinations strategies. Eventually, we provide some sufficient conditions for a scaling…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPrion Diseases and Protein Misfolding · Mathematical Biology Tumor Growth · SARS-CoV-2 and COVID-19 Research
